Hospira to Acquire API Manufacturing and R&D Facilities
08:41 EDT 29 Aug 2012 | PharmPro
Hospira, Inc. has today announced an agreement for the company to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated research and development (R&D) facility, from Orchid Chemicals & Pharmaceu..
Original Article: Hospira to Acquire API Manufacturing and R&D Facilities
More From BioPortfolio on "Hospira to Acquire API Manufacturing and R&D Facilities"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
